Iglehart JD - Search Results

1

Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.

Bluman LG, Rimer BK, Berry DA, Borstelmann N, Iglehart JD, Regan K, Schildkraut J, Winer EP. Bluman LG, et al. Among authors: iglehart jd. J Clin Oncol. 1999 Mar;17(3):1040-6. doi: 10.1200/JCO.1999.17.3.1040. J Clin Oncol. 1999. PMID: 10071299 Clinical Trial.

2

Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.

Bluman LG, Rimer BK, Regan Sterba K, Lancaster J, Clark S, Borstelmann N, Iglehart JD, Winer EP. Bluman LG, et al. Among authors: iglehart jd. Psychooncology. 2003 Jul-Aug;12(5):410-27. doi: 10.1002/pon.653. Psychooncology. 2003. PMID: 12833555

3

Overestimation of hereditary breast cancer risk.

Iglehart JD, Miron A, Rimer BK, Winer EP, Berry D, Shildkraut MJ. Iglehart JD, et al. Ann Surg. 1998 Sep;228(3):375-84. doi: 10.1097/00000658-199809000-00010. Ann Surg. 1998. PMID: 9742920 Free PMC article.

4

Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis.

Parmigiani G, Berry DA, Winer EP, Tebaldi C, Iglehart JD, Prosnitz LR. Parmigiani G, et al. Among authors: iglehart jd. J Clin Oncol. 1999 May;17(5):1465-73. doi: 10.1200/JCO.1999.17.5.1465. J Clin Oncol. 1999. PMID: 10334532

5

Testing for hereditary breast and ovarian cancer in the southeastern United States.

Miron A, Schildkraut JM, Rimer BK, Winer EP, Sugg Skinner C, Futreal PA, Culler D, Calingaert B, Clark S, Kelly Marcom P, Iglehart JD. Miron A, et al. Among authors: iglehart jd. Ann Surg. 2000 May;231(5):624-34. doi: 10.1097/00000658-200005000-00002. Ann Surg. 2000. PMID: 10767783 Free PMC article. Clinical Trial.

6

Pre-counseling education materials for BRCA testing: does tailoring make a difference?

Skinner CS, Schildkraut JM, Berry D, Calingaert B, Marcom PK, Sugarman J, Winer EP, Iglehart JD, Futreal PA, Rimer BK. Skinner CS, et al. Among authors: iglehart jd. Genet Test. 2002 Summer;6(2):93-105. doi: 10.1089/10906570260199348. Genet Test. 2002. PMID: 12215248

7

Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status.

Blackwell K, Haroon Z, Broadwater G, Berry D, Harris L, Iglehart JD, Dewhirst M, Greenberg C. Blackwell K, et al. Among authors: iglehart jd. J Clin Oncol. 2000 Feb;18(3):600-8. doi: 10.1200/JCO.2000.18.3.600. J Clin Oncol. 2000. PMID: 10653875 Clinical Trial.

8

Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ.

Bluman LG, Borstelmann NA, Rimer BK, Iglehart JD, Winer EP. Bluman LG, et al. Among authors: iglehart jd. J Womens Health Gend Based Med. 2001 Jul-Aug;10(6):589-98. doi: 10.1089/15246090152543175. J Womens Health Gend Based Med. 2001. PMID: 11559456

9

Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.

Marks JR, Humphrey PA, Wu K, Berry D, Bandarenko N, Kerns BJ, Iglehart JD. Marks JR, et al. Among authors: iglehart jd. Ann Surg. 1994 Apr;219(4):332-41. doi: 10.1097/00000658-199404000-00002. Ann Surg. 1994. PMID: 7909221 Free PMC article.

10

Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis.

Peters KG, Coogan A, Berry D, Marks J, Iglehart JD, Kontos CD, Rao P, Sankar S, Trogan E. Peters KG, et al. Among authors: iglehart jd. Br J Cancer. 1998;77(1):51-6. doi: 10.1038/bjc.1998.8. Br J Cancer. 1998. PMID: 9459145 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters